Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tight junction protein claudin-1 (CLDN1) is a transmembrane protein belonging to the claudin family, which are essential components of tight junctions in epithelial and endothelial cells[1][2][4]. Claudin-1 consists of four transmembrane domains, two extracellular loops, and cytoplasmic N- and C-termini, with its C-terminus containing a PDZ domain-binding motif for interactions with scaffolding proteins like ZO-1[1][4]. CLDN1 plays a critical role in regulating paracellular barrier permeability, maintaining cell–cell adhesion, tissue homeostasis, and modulating signaling pathways relevant to cell growth and differentiation[1][4]. Its deregulated expression is a hallmark in several cancers, where it acts as either a tumor promoter or suppressor depending on context, affects metastasis, and is under investigation as a therapeutic target[2]. It is also significant in infection biology, as it serves as a co-receptor for hepatitis C virus entry. Drugs targeting claudin-1 or its complexes modulate tight junction function, with recent research focusing on specificity and safety of such agents for barrier reinforcement, cancer therapy, or antiviral strategies[3][4].
Direct disruption or modulation of tight junctions; Induced change in paracellular permeability/barrier function[3]; Blocking viral entry (e.g., HCV)[2]
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tight junction protein claudin-1 (CLDN1).